Professor of Medicine
Chief, Lymphoma/Myeloma Service
Head, Lymphoma Transitional Research Laboratory
Roswell Park Cancer Institute
Buffalo, New York
Myron S. Czuczman, MD, is professor of medicine, chief of the Lymphoma/Myeloma Service, and head of the Lymphoma Transitional Research Laboratory at Roswell Cancer Institute in Buffalo, New York. Dr. Czuczman earned his medical degree from the Pennsylvania State University College of Medicine. He completed his internship and residency training at Cornell's North Shore University Hospital/Memorial Sloan-Kettering Cancer Program in Manhasset, New York, and completed a medical oncology/hematology and a senior research fellowship in hematopoietic cancer immunochemistry at Memorial Sloan-Kettering Cancer Center.
Dr. Czuczman's research interests focus on monoclonal antibodies either alone or in combination with other agents in the treatment of lymphoma, evaluating novel target-specific molecules active against lymphoma in the clinic and laboratory, and studying the mechanisms-of-action and resistance pathways involving monoclonal antibodies currently used in lymphoma therapy.
Dr. Czuczman is a member of the American Association of Cancer Research, the American Society of Hematology, and the American Society of Clinical Oncology. He also serves on the National Comprehensive Cancer Network (NCCN) Lymphoma Guidelines Panel, the NCCN non-Hodgkin's Lymphoma Outcomes Database Panel, and is a cadre member of the Lymphoma Committee of the Cancer and Leukemia Group B (CALGB) national cooperative group.
Dr. Czuczman has authored or coauthored more than 350 journal publications, book chapters and abstracts. He is a journal reviewer for the Journal of Clinical Oncology, Cancer, Clinical Cancer Research, Blood, Cancer Investigation, Annals of Hematology, Cancer Research, and American Journal of Hematology.